8 March 2022 - Written by Philip Turton
1965 is the Watershed: Watt v Lend Lease Construction (Europe) Ltd
Philip Turton considers the decision of Lord Uist in the Scottish mesothelioma case of Watt v Lend Lease Construction (Europe) Ltd [2022] CSOH 23, an interesting decision from north of the border (judgment ...
20 January 2022 - Written by Jonathan Owen & Jessica Woodliffe
Court of Appeal Rejects Insurers' Challenge to CRU Scheme
On 14 January 2022, the Court of Appeal handed down judgment in Aviva Insurance Ltd & Anor v Secretary of State for Work and Pensions [2022] E...
9 November 2021 - Written by Philip Turton
Oh Flower of Scotland... Haggerty-Garton v ICI [2021] EWHC 2924 (QB)
On 3 November 2021 the newly appointed Ritchie J handed down his judgment in Haggerty-Garton v ICI [2021] EWHC 2924 (QB), a mesothelioma case brought in the High Court but, pursuant to a consent order agreed between the First Claimant and the Defendant, ...
13 September 2021 - Written by Philip Godfrey
SURPRISE! Now, Show Cause!
On 27 July 2021, the Court of Appeal handed down judgment in Ministry of Defence v Sivaji [2021] EWCA Civ 1163 which addresses the procedural rules f...
22 June 2021 - Written by Nikhil Arora
Success Fees in Mesothelioma Cases: Moutarde v SIG Logistics
In this blog, Nik Arora reviews the decision in Moutarde v SIG Logistics to limit the Claimant's success fee in a mesothelioma claim to 27.5%. Q. When is a trial not a trial? ...
17 May 2021 - Written by Richard Gregory
Non-Party Disclosure and CPR 31.17: Sparkes v London Pension Funds Authority & Leigh Academies Trust
A good month for claimants in historic asbestos claims continues. Coming shortly after Scarborough College Ltd v Winter [2021] EWHC 1549 (QB), in which a Show Cause finding in a claimant’s favour was undisturbed on appeal (...
6 May 2021 - Written by Philip Godfrey & Alexandra Pountney
Scarborough College v Winter: Spotlight on the Show Cause Procedure
In Scarborough College Ltd v Winter [2021] EWHC 1549 (QB), the High Court considered an appeal by a Defendant against the decision of a Master to enter judgment under CPR PD3D (the show cause procedure). The appeal was dismissed. Cavanagh J held that Jud...
19 January 2021 - Written by Thomas Herbert
Court of Appeal Considers 'Lost Years' Claims in Head v The Culver Heating Co Ltd
In a judgment handed down on 18 January 2021 in Head v The Culver Heating Co Ltd [2021] EWCA Civ 34, the Court of Appeal unanimously allowed an appeal against the decision of HHJ Melissa Clarke dismissing the Claimant's 'lost years' claim. The judge had dismi...
18 January 2021 - Written by Jessica Woodliffe
Latest Instalment in Insurers' Challenge to CRU Provisions
In R (on the application of (1) Aviva Insurance Ltd (2) Swiss Reinsurance Company Ltd) v The Secretary of State for Work and Pensions [2021] EWHC 30 (Admin), Henshaw J dealt with certain consequential matters arising from his ...
14 December 2020 - Written by Abigail Scott
IIAC Announces Review of the Relationship Between Respiratory Diseases and Occupational Exposures
The Industrial Injuries Advisory Council (IIAC) has announced its intention to conduct a review of selected malignant and non-malignant respiratory diseases and their relationships with occupational exposures. The IIAC is the advis...
30 November 2020 - Written by Jessica Woodliffe
Certain Compensation Recovery Unit Payments Declared Incompatible with the European Convention on Human Rights
In R (on the application of (1) Aviva Insurance Ltd (2) Swiss Reinsurance Company Ltd) v The Secretary of State for Work and Pensions [2020] EWHC 3118 (Admin), the Claimants challenged the unintended and onerous consequences of the Compensation Recovery Unit ...
23 October 2020
Ropewalk Chambers One of Only Four Sets Ranked for Industrial Disease in Chambers & Partners 2021
Following our recent success in the Legal 500 2021, Chambers' expertise in the field of industrial dis...
3 October 2020 - Written by Philip Turton
Nivolumab and Ipilimumab Approved as Immunotherapy Treatments in the USA
On 2 October 2020, the American Food & Drug Administration approved a combination of nivolumab (OPDIVO, Bristol-Myers Squibb Co) and ipilimumab (YERVOY, Bristol-Myers Squibb Co) as a first-line treatment for adults with unresectable mesothelioma. Randomi...
Ropewalk Chambers has, over many decades, established a market-leading reputation for detailed and specialist expertise in the field of Industrial Disease litigation.
Whether asbestos, noise, dust, vibration, stress or any other insidious process, including those which are newly emerging, its members have consistently appeared in the leading cases, determining the limits of liability, causation and quantum at first instance and appellate level.
Work is distributed within Chambers to enable Members of Chambers to represent both Claimants and Defendants in this field.
To find out more about our Disease barristers, click here.
Search blog by title or barrister
Subscribe for blog updates
Search by keyword
- Air Pollution
- Apportionment
- Asbestos
- Beryllium
- Bladder Cancer
- Breach of Duty
- Cancer
- Causation
- Civil Procedure
- Companies
- Compensation Recovery Unit
- Concussion
- Contributory Negligence
- Costs
- Covid
- CTE
- Damages
- Dementia
- Dupuytren's Contracture
- Dust Diseases
- Evidence
- Expert Evidence
- Fatal Accidents
- Immunotherapy
- Inquests
- Insolvency
- Jurisdiction
- Legal Directories
- Limitation
- Lung Cancer
- Mesothelioma
- Noise-Induced Hearing Loss
- Restoration of Companies
- Silicosis
- Sport
Recent Posts
- Disputing Joint Engineering Evidence: Donald Round v West Midlands Travel Ltd
- 1965 is the Watershed: Watt v Lend Lease Construction (Europe) Ltd
- Court of Appeal Rejects Insurers' Challenge to CRU Scheme
